This pilot and feasibility study will enroll newly pregnant women with high SED and elevated APO risk (n=53) and randomize them to either a SED reduction intervention or control. Research aims include to: 1) demonstrate our ability to decrease SED and increase light activity in pregnant women; 2) evaluate feasibility; and 3) gather preliminary effects on clinical outcomes including APOs, cardiometabolic risk factors, well-being, and fetal outcomes.
Our innovative, high-impact project is the next logical step to inform a larger randomized clinical trial. This transformative research is a first step toward our long-term goal of providing a novel, evidence-based strategy to prevent APOs during pregnancy and reduce CVD in women and their children.